Xi Li

This inventor holds 18 USPTO granted patents and 10 published patent applications and 7 EPO patents. Top assignees: Huawei Technologies Co., Limited, Duality Biologics (Suzhou) Co., Ltd., Chinese Academy of Sciences. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xi Li. Retrieved from https://idiyas.com/inventor/xi-li-b6hx1n63

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 10)

% Patents Active = 94.4

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 50(Granted Patents)

Location History:

Shenzhen, CN (2018)
Hefei, CN (2019 - 2022)
Shanghai, CN (2015 - 2024)

Company Filing History:

7 out of 27,557

Huawei Technologies Co., Limited

patents

6 out of 7

Duality Biologics (Suzhou) Co., Ltd.

patents

3 out of 3,358

Chinese Academy of Sciences

patents

4. 2 out of 3

Anhui Transilica Microelectronics Co., Ltd.

patents

5. 2 out of 2

Jiangsu Keda Hengxin Semicon Tech Co., Ltd.

patents

6. 2 out of 104

University of Science and Technology of China

patents

7. 1 out of 2,332

Huawei Technologies Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12664122 - Process management method and electronic device (2026-06-23),

2. 12434077 - Anti-tumor compound and preparation method and use thereof (2025-10-07),

3. 12168667 - Anti-tumor compound and preparation method and use thereof (2024-12-17),

4. 12091418 - Anti-tumor compound and preparation method and use thereof (2024-09-17),

5. 11952384 - Anti-tumor compound and preparation method and use thereof (2024-04-09),

6. 11856424 - Method for creating network simulation platform, network simulation method, and corresponding apparatuses (2023-12-26),

7. 11685742 - Anti-tumor compound and preparation method and use thereof (2023-06-27),

8. 11607459 - Anti-tumor compound and preparation method and use thereof (2023-03-21),

9. 11394172 - Laser driver with high-speed and high-current and integrated circuit thereof (2022-07-19),

10. 11095093 - Laser driver with high-speed and high-current and current modulating method thereof (2021-08-17),

11. 10908923 - Application starting method and terminal device (2021-02-02),

12. 10887401 - Device connection method and terminal (2021-01-05),

13. 10679697 - Read circuit of storage class memory with a read reference circuit, having same bit line parasitic parameters and same read transmission gate parasitic parameters as memory (2020-06-09),

14. 10552222 - Task scheduling method and apparatus on heterogeneous multi-core reconfigurable computing platform (2020-02-04),

15. 10452605 - Method and apparatus for task scheduling on heterogeneous multi-core reconfigurable computing platform (2019-10-22),

Title: The Innovative Journey of Xi Li: Pioneering Anti-Tumor Research in Shanghai

Introduction

Xi Li, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals through his innovative approaches to anti-tumor compounds. With an impressive portfolio comprising 16 patents, Li's work continues to influence the landscape of cancer treatment and research.

Latest Patents

Among his latest patents is an advanced anti-tumor compound and its associated preparation method. This patent specifically focuses on a novel compound or its variants, including tautomers, mesomers, racemates, enantiomers, diastereoisomers, or a mixture thereof. It also discusses the pharmaceutical applications of the compound, highlighting its potential usefulness in combating tumors.

Career Highlights

Xi Li has showcased his expertise while working at prominent companies such as Huawei Technologies Co., Limited and Duality Biologics (Suzhou) Co., Ltd. His experiences in these organizations have enabled him to refine his skills in research and development, particularly in the biotechnology sector.

Collaborations

Throughout his career, Xi Li has collaborated with esteemed colleagues, including Yu Zhang and Zhongyuan Zhu. These partnerships have contributed to his growth as an inventor and have enhanced the innovative potential of the projects he has undertaken.

Conclusion

In summary, Xi Li stands out as a key figure in the realm of anti-tumor research, with a rich history of patents that reflect his commitment to innovation. His work not only exemplifies the spirit of invention but also demonstrates the significant impact that inventive minds can have on global health challenges. The future looks promising for Xi Li as he continues to push the boundaries of what is possible in cancer treatment.

Profile summary based on public USPTO records.